GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bio Essence BIOE · USD

N/A · US listing · 🇺🇸 United States

Compare

0.47

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.9m

FY2017FY2025

Net income

$896,197

FY2017FY2025

Free cash flow

$1.6m

FY2017FY2025

Shareholders' equity

−$2.1m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$1.9m$323,940$551,506$621,590$887,984$958,700$826,306$984,575$1.3m
Operating income$900,011−$459,438−$782,803−$511,138−$857,527−$832,566−$1.7m−$1.5m−$1.7m
Net income$896,197−$1.3m−$971,879−$809,679−$647,564−$595,838−$1.7m−$1.5m−$1.8m
Diluted earnings per share0.02-0.03-0.03-0.02-0.02-0.02-0.05-0.05-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$422,474$281,024$2.7m$1.5m$1.7m$1.8m$2.3m$1.0m$1.9m
Cash and short-term investments—$1,371$114$6,262$303$5,325$16,160−$64,683$713,551
Total liabilities$2.5m$3.3m$4.3m$4.8m$4.1m$3.6m$3.4m$852,846$357,812
Debt$1.6m$2.7m$3.5m$4.6m$4.0m$3.0m$2.3m$124,894—
Shareholders' equity−$2.1m−$3.0m−$1.7m−$3.2m−$2.4m−$1.8m−$1.1m$169,432$1.5m
Shares outstanding38m38m36m33m33m33m33m32m51m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$1.6m$623,865−$1.0m−$703,241−$1.3m−$732,744−$896,922−$831,004−$2.1m
Capital spending−$3−$5−$3,614−$59,120−$119,496−$7,365−$27,650−$96,733−$91,646
Free cash flow$1.6m$623,860−$1.0m−$762,361−$1.4m−$740,109−$924,572−$927,737−$2.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$794,711$500,537$1.5m$136,800$259,123$22,189$147,555$134,690
Operating income$279,290$215,795$1.0m$14,253$61,223−$205,151$3,852−$146,448
Net income$270,077$205,373$1.0m$12,998$59,864−$205,752−$27,563−$1.2m
Diluted earnings per share0.010.000.030.000.00-0.01-0.00-0.03
Cash from operations——$1.0m—————
Total assets$4.0m$789,032$422,474$184,534$112,692$365,718$281,024$715,973
Cash and short-term investments$675$36,177—$28,741——$1,371$29,818
Debt$1.6m$1.6m$3.1m$3.9m$2.5m$2.5m$2.3m$2.6m
Shareholders' equity$2.3m−$1.4m−$2.1m−$3.1m−$3.1m−$3.2m−$3.0m−$2.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue45.1%14.6%—

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings1.6-4.3
Price to sales0.717.3

Share price return

Finished calendar years

20252024
Return-81%25%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.